Business Description
OneSource Specialty Pharma Ltd
ISIN : INE013P01021
Total Employee Number:
1,412Compare
Compare
Traded in other countries / regions
544292.India IPO Date
2025-01-24Description
OneSource Specialty Pharma Ltd is engaged in the research, development, manufacture and commercialization of biological drug products in different injectable formats. The company also offers end-to-end CDMO services across all phases of pre-clinical and clinical development and commercial supply of biologics. The company's reportable segments are CDMO (Contract Development and Manufacturing Organization (CDMO) : Development and manufacture of pharmaceutical products and associated services); and Unit-3 Multimodal Facility and CDMO-2.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.08 | |||||
Equity-to-Asset | 0.71 | |||||
Debt-to-Equity | 0.26 | |||||
Debt-to-EBITDA | 4.41 | |||||
Interest Coverage | 0.45 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 4.65 | |||||
Beneish M-Score | -1.97 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 232.2 | |||||
3-Year EPS without NRI Growth Rate | 37.6 | |||||
3-Year FCF Growth Rate | -39.4 | |||||
3-Year Book Growth Rate | 95 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 30.07 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 27.85 | |||||
9-Day RSI | 34.43 | |||||
14-Day RSI | 37.87 | |||||
3-1 Month Momentum % | -8.62 | |||||
6-1 Month Momentum % | 27.8 | |||||
12-1 Month Momentum % | -12.25 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.99 | |||||
Quick Ratio | 0.68 | |||||
Cash Ratio | 0.08 | |||||
Days Inventory | 226.05 | |||||
Days Sales Outstanding | 139.63 | |||||
Days Payable | 204.4 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.1 | |||||
Shareholder Yield % | -2.6 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 67.83 | |||||
Operating Margin % | 3.63 | |||||
Net Margin % | -3.15 | |||||
EBITDA Margin % | 22.11 | |||||
FCF Margin % | -36.32 | |||||
OCF Margin % | 0.55 | |||||
ROE % | -0.83 | |||||
ROA % | -0.61 | |||||
ROIC % | 0.53 | |||||
3-Year ROIIC % | 4.29 | |||||
ROC (Joel Greenblatt) % | 3.69 | |||||
ROCE % | 0.88 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 45.8 | |||||
PS Ratio | 11.26 | |||||
PB Ratio | 2.98 | |||||
Price-to-Tangible-Book | 33.05 | |||||
Price-to-Operating-Cash-Flow | 2032.59 | |||||
EV-to-EBIT | 321.49 | |||||
EV-to-EBITDA | 54.87 | |||||
EV-to-Revenue | 12.14 | |||||
EV-to-FCF | -33.86 | |||||
Earnings Yield (Greenblatt) % | 0.31 | |||||
FCF Yield % | -3.23 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
OneSource Specialty Pharma Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 15,433.43 | ||
| EPS (TTM) (₹) | -4.25 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 52.42 | ||
| 14-Day RSI | 37.87 | ||
| 14-Day ATR (₹) | 48.290744 | ||
| 20-Day SMA (₹) | 1569.2475 | ||
| 12-1 Month Momentum % | -12.25 | ||
| 52-Week Range (₹) | 1075 - 1924 | ||
| Shares Outstanding (Mil) | 114.67 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
OneSource Specialty Pharma Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
OneSource Specialty Pharma Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
OneSource Specialty Pharma Ltd Frequently Asked Questions
What is OneSource Specialty Pharma Ltd(BOM:544292)'s stock price today?
The current price of BOM:544292 is ₹1512.25. The 52 week high of BOM:544292 is ₹1924.00 and 52 week low is ₹1075.00.
When is next earnings date of OneSource Specialty Pharma Ltd(BOM:544292)?
The next earnings date of OneSource Specialty Pharma Ltd(BOM:544292) is .
Does OneSource Specialty Pharma Ltd(BOM:544292) pay dividends? If so, how much?
OneSource Specialty Pharma Ltd(BOM:544292) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on OneSource Specialty Pharma Ltd
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers